Today we are pleased to share construction plans for a new manufacturing facility at AGC Inc.’s Yokohama Technical Center in Japan. Our large-scale facility will be centrally located in this important APAC market, and will support global developers seeking biopharmaceutical product development and manufacturing.
AGC Biologics Yokohama will offer services from pre-clinical to commercial stages, including cell therapy, mRNA, and large-scale mammalian cell culture capacity.
Upon completion, this will be one of Japan’s largest sites for mammalian-based manufacturing capacity.
[…]